Page last updated: 2024-11-01

niflumic acid and Disease Exacerbation

niflumic acid has been researched along with Disease Exacerbation in 2 studies

Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"As such, an ovarian cancer cell line, OV-90, was cultured in adherent and non-adherent conditions using stable isotope labeling with amino acids in cell culture (SILAC)."1.42Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1). ( Batruch, I; Diamandis, EP; Karagiannis, GS; Musrap, N; Saraon, P; Tuccitto, A, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Musrap, N1
Tuccitto, A1
Karagiannis, GS1
Saraon, P1
Batruch, I1
Diamandis, EP1
Rangel Moreno, J1
Estrada García, I1
De La Luz García Hernández, M1
Aguilar Leon, D1
Marquez, R1
Hernández Pando, R1

Other Studies

2 other studies available for niflumic acid and Disease Exacerbation

ArticleYear
Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).
    The Journal of biological chemistry, 2015, Jul-10, Volume: 290, Issue:28

    Topics: Cell Adhesion; Cell Aggregation; Cell Line, Tumor; Chloride Channels; Disease Progression; Female; G

2015
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis.
    Immunology, 2002, Volume: 106, Issue:2

    Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors;

2002